1.
General information S1-S2
Synthesis of Materials S3
3. Characterization of phospholipid-poly(ethylene) glycol (PL-PEG) S4
4.
Characterization of oxidized HiPco SWCNTs (ox-SWCNT) S5-S7
5.
Characterization of DOX-SWCNT S8-S9
6. Myeloperoxidase-catalysed degradation experiments with hydrogen peroxide, and chloride (MPO/H 2 O 2 /Clˉ) S10
7. TEM images of degradation under MPO/H 2 O 2 /Clˉ S11 8. Proposed degradation products of DOX S12-S13
9.
Identification of a degradation product S14-S16
10.
Degradation experiments with peroxynitrite S17
11. Characterization of peroxynitrite-mediated oxidation S18
12. Zeta potential titration with MPO S19
13. Methods of in vitro studies S20-S21 S2 spectroscopy (XPS) was obtained via a Thermo Scientific ESCALAB 250xi photoelectron spectrometer using monochromated Al K Alpha X-rays as the source. A reverse-phase LC/MS (LC/MS-2020 Shimadzu) equipped with a Phenomenex C18 column and a photodiode array (PDA) detector was utilized. MALDI mass spectra were recorded on a MALDI, Voyager-DE PRO Instrument. Zeta potential was measured using a Brookhaven ZetaPals at 25 ˚C under specified conditions of pH. NMR spectra were acquired on a Bruker Avance III 400MHz NMR. Chemical shifts were reported in ppm (δ) relative to residual solvent peaks (DMSO-d 6 = 2.50 ppm for 1 H).
Coupling constants (J) were reported in Hz. C18 column chromatography was performed on a C 18 -reversed phase silica gel purchased from Sigma-Aldrich.
S3

Synthesis of materials
Raw HiPco (NanoIntegris®) single-walled carbon nanotubes (25 mg) were oxidized in 50 mL of an acid mixture (H 2 SO 4 /HNO 3 , 3/1, v/v) in an ultrasonic bath set at 25 ˚C over 3 h 20 min.
After thorough washing with distilled water several times, the oxidized nanotubes were dried under vacuum over 24 h, which yielded 18 mg of OX-SWCNTs. A phospholipid functionalized PEG (PL-PEG) was prepared by an amide coupling with DSPE-050PA (115 mg) and TMS(PEG) 12 (71 mg) in anhydrous dichloromethane (3.0 mL). After 12 h, in the case when much of the reactants still remained due to mostly the hydrolyzed -N-hydroxysuccinimide (NHS) group of TMS(PEG) 12 , N,N-Dicyclohexylcarbodiimide (DMAP) (20 mg) and 4-dimethylaminopyridine (10 mg) were added, and amide formation proceeded . After 24 h of stirring at room temperature, the solvent was dried, and the reaction mixture was washed with nanopure water (61 mL) and was collected through vacuum filtration. Excess DMAP was further removed through dialysis. This reaction gave an average MW of ca. 7.4-8.2 kDa of PL-PEG (Fig. S1 ).
The ox-SWCNTs were sonicated with PL-PEG in phosphate buffer (pH 8.2) for 1 h and then stirred at room temperature. The PEGylated ox-SWCNT was washed low molecular weight PEG chains with ultracentrifugation (11,000 rpm, 30 min × 3) using a 100 kDa Amicon centrifugal filter.
Doxorubicin (4.8 mg) was dissolved in 10 mL of phosphate buffer (0.1 M, pH 8.2). The DOX solution was sonicated for 30 min and was stirred overnight. After thorough washing with the same buffer solution through centrifugation, the amount of DOX wash-off was calculated from a UV-Vis calibration curve. The reaction gave about 2.3 mg of DOX bound to 3.0 mg of ox-SWCNT/PL-PEG, which gave a 77% of drug loading. This estimation differs by 23% from the UV-Vis titration (Fig. S6 ).
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Characterization of phospholipid-polyethylene glycol (PL-PEG)
MALDI mass spectrometry A matrix solution was prepared with α-Cyano-4-hydroxycinnamic acid (10.0 mg) in a 2 mL mixture of equal volumes of 0.2 % of trifluoroacetic acid (TFA) in H 2 O and CH 3 CN. A PL-PEG was dispersed in water (1 mg/mL) and then mixed with the prepared CH 3 CN/TFA solution (1:1, v/v). 
Characterization of oxidized HiPco SWCNTs (ox-SWCNT)
Raman spectroscopy Dried nanotubes were drop-cast on a microscope slide. Spectra were collected with a 10 second exposure time and averaged across 5 scans per location. The collected spectra were normalized to 1 with respect to the maximum intensity. After 3 h 20 min of an acid treatment (H 2 SO 4 : HNO 3 , 3:1, v/v) with ultrasonication, the D band became wider and was shifted to a higher wavenumber. I D /I G of the ox-SWCNT was substantially larger than that of the pristine SWCNT, indicating the higher degree of functionalization. Using KBr as the background and taking 32 scans per sample, a spectrum was obtained over the range of 800 to 4000 cm -1 with a resolution of 4 cm -1 .
Fig. S3
Fourier transform infrared spectrum of ox-SWCNT.
X-ray photoelectron spectroscopy (XPS)
The spot size of the sample was 400 µm (microns) prepared on an aluminum plate. Charge compensation was provided by a low energy electron source and Ar + ions. Survey scans were collected using a pass energy of 150 eV, and high resolution scans were collected using a pass energy of 50 eV. The average percentage indicates a mean obtained by analyzing three different sample spots.
Peak (cm S1 The maximum binding ratio of DOX to ox-SWCNT/PL-PEG was determined from the fitting curve.
UV-Vis titration determining the binding ratio of ox-SWCNT/PL-PEG with DOX
When the value of ΔA (ΔA = A bound DOX -A freeDOX ) reaches the maximum, the binding of DOX to the nanotube is saturated, in which the wt equiv value (x) of the maximum is 0.964. Therefore, a 1:1 weight ratio of DOX to ox-SWCNT/PL-PEG was obtained from the fitting equation below.
(R 2 = 0.9870) Using a graphical linear fitting curve near the saturation point at y-axis (0 mV), the corresponding wt equiv value was estimated. Approximately at 1.124 equiv, the zeta potential remains constant.
Here, a 1.1:1 binding ratio of DOX to ox-SWCNT/PL-PEG was found. The graphical linear fit was obtained by OriginPro 8.5. The -OH groups undergo a transformation into the carbonyl groups of 6, S2 and the primary amine group are chlorinated selectively in 7.
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Simultaneously, compound 11 can be formed from phenolic (-OH) groups of ox-SWCNTs. If the nanotubes contain dangling bonds terminated with -C=C-although this constituent is not abundant, S4 compound 12 may provide another competing reaction with DOX.
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Compounds 8 and 9 were previously identified in MPO/H 2 O 2 /NO 2ˉ, in which nitrite, a strong oxidant (or cofactor), promotes reduction of the hydroquinone moiety of the B-ring (Scheme 1). S5 However, this pathway seems to less likely occur in our MPO/H 2 O 2 /Clˉ system.
Compound 3 is a known metabolite resulting from cleavage of the daunosamine by hydrolysis S6 although its mechanism has not been well understood. However, 3 was not found in the control condition. In the case of in vivo experiments, we may see more different degradation pathways. Compounds 3 and 5 can be formed under reductive environments in cells. Cellular enzymes such as NADPH-cytochrome P450 reductase and flavoenzymes initiate transformation of the quinone of DOX to semiquinone (1eˉ reduction) or hydroquinone (2eˉ reduction). S7 Compound 5 is formed by conversion of a ketone to an alcohol in ring A. Compound 3 is associated with various pathways, including electron transfer and quinone methide formation. S8 No matter how the reduction process proceeds, DOX will eventually cleave the daunosamine, and a new bond is formed with nucleophiles, electrophiles, or radicals besides the hydroxyl group at C7 depending on the degradation pathway.
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Identification of a degradation product (compound 4)
1 H NMR analysis In order to collect a large amount of sample for analysis, the weight and volume of each Doxorubicin solution was scaled up by 48 times while maintaining the same concentration used in the UV-Vis-NIR experiments. After incubation, the water in the samples was removed using SpeedVac over 6.5 h. The collected solid contained Doxorubicin degradation products and phosphate salt. Using methanol, N,N-dimethylformamide (DMF) and toluene, the collected samples were washed thoroughly and dried with a rotary evaporator and then a high vacuum pump over 24 h. 
Degradation experiments with peroxynitrite
Each DOX-SWCNT sample had a concentration of 0.03 mg of DOX-SWCNT in 808 µL of phosphate buffer (pH 7.4, 0.1 M), and 0.02 mg/mL of free DOX was prepared in the same buffer.
Stock solutions of all other reagents were prepared every day. Then 7.5 μL of a xanthine oxidase (XO) solution (×50 diluted from the original enzyme) containing 0.15-0.3 mU of XO, was added per day, followed by additions of 7.5 μL of xanthine solution (7.0 mM) and 7.5 μL of a PAPA NONOate solution (3.5 mM) every 2 h (total 6 times per day). Due to the dilution effect, the concentrations of both xanthine and PAPA NONOate solutions were raised after 6 additions, maintaining the same amount of each reagent relative to the total volume of the DOX-SWCNT solution. After incubation over a given time period, all the samples were filtered using Amicon centrifuge filters (size: 1,000 Da). The filtrate and the concentrate were separately collected by ultracentrifuge (14,000 × g, 10 min), and the concentrate was further diluted in phosphate buffer 
Zeta potential titration with MPO
The laser of the zeta potential analyzer was set at 532 nm. The zeta potential of unbound pure MPO was measured separately, which gave a negative potential (−9.0 ± 1.7 mV). A rapid color change to a very bright yellow upon the laser irradiation suggests the photosensitive heme of MPO. S10 
In vitro cell studies
Mice Pathogen-free C57BL/6 mice (7-8 wk old) mice from Jackson Labs (Bar Harbor, ME, USA)
were individually housed and acclimated for 2 weeks. Animals were supplied with water and food ad libitum and housed under controlled light, temperature, and humidity conditions. All animal studies were conducted under a protocol approved by the Institutional Animal Care and Use
Committee.
Cell B16 melanoma cells were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA) and maintained in RPMI 1640 medium that was supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, 10 mM HEPES, 10% heat-inactivated FBS, 0.1 mM nonessential amino acids, and 1 mM sodium pyruvate (Invitrogen Life Technologies, Inc., Grand
Island, NY, USA). Tumor conditioned medium was collected from sub-confluent cultures, centrifuged (300 g, 15 min) and cell-free supernatant was collected, aliquoted and used to treat MDSC.
For MDSC generation, bone marrow cells from tibia were isolated, filtered through a 70 m cell strainer, and red blood cells were lysed with lysing buffer (155 mM NH 4 Cl in 10 mM Tris-HCl buffer pH 7.5, 25°C) for 3 min. After RBC lysis, cells were washed and used for MDSC sorting. Amicon centrifugal filter (11,000 rpm, 10 min), and the concentration of free DOX was measured using UVVis at 480 nm. The error bars indicate the means ± SD of three replicate measurements. 
